Objective: Acute aortic occlusion (AAO) is a life-threatening event necessitating prompt revascularization to the pelvis and lower extremities. Because of its uncommon nature, outcomes after revascularization for AAO are not well characterized. Our aim was to describe the perioperative morbidity and mortality associated with revascularization and to identify the patients at highest risk.
Acute aortic occlusion (AAO) is a potentially fatal disease that requires prompt diagnosis and intervention to prevent the high rates of associated morbidity and mortality. Common causes of AAO include in situ thrombosis of atherosclerotic aortoiliac occlusive disease, acute thrombosis of abdominal aortic aneurysms, and embolism to the aortoiliac bifurcation. 1 Despite the potentially catastrophic consequences of AAO, with mortality rates reported as high as 100%, 2 there is a paucity of information on this vascular emergency. The largest study in the current literature reflects a single-center experience of 48 patients published in 1995. 1 These investigators reported a mortality rate of 52%, with patients treated by a combination of aortobifemoral bypass, axillobifemoral bypass, and isolated aortoiliac thromboembolectomy. Since that time, endovascular therapy has transformed the way in which chronic aortoiliac arterial occlusive disease is managed. For patients presenting with AAO, primary or optimal modes of treatment and factors that affect perioperative mortality and complication rates in the modern endovascular era have yet to be defined. Contemporary studies of patients with AAO that reflect these changes in practice patterns remain limited by small sample sizes, thus limiting a provider's ability to appropriately counsel patients on modern postoperative expectations, prognosis, and outcomes. [3] [4] [5] [6] Our objective was to retrospectively review our large institutional experience with AAO with different revascularization treatment strategies and to characterize specific risk factors that are associated with postoperative mortality and morbidity. Review of our experience in the context of the available literature may aid in appropriate patient-centered revascularization strategies that lead to improved outcomes after these vascular emergencies.
METHODS
This study was approved by the Institutional Review Board at the University of Pittsburgh. The need for informed consent was waived. We performed a retrospective review of patients who underwent revascularization after presenting to our institution between 2006 and 2017 with acute occlusion of the distal aorta (AAO). Patients with prior iliac stents were included, but those with prior aortofemoral bypasses were excluded as the pathophysiologic process of graft occlusion was thought to be distinct from that of native vessel occlusion. We additionally excluded patients with aortic dissection, trauma, or other nonthrombotic causes of AAO. Patients without at least a unilateral lower extremity motor or sensory deficit were considered to be a distinct chronic entity and were also excluded. At our institution, patients presenting with AAO were revascularized by four different treatment modalities, all of which were included in our study cohort. Axillobifemoral bypass was most commonly used; less often, aortoiliac thromboembolectomy with or without aortoiliac stenting and aortobifemoral bypass were performed in selected patients.
Data were collected from review of the electronic medical record. Baseline characteristics including demographics, comorbidities, presenting laboratory values, and relevant surgical history were collected. Although some patients were taken to the operating room without confirmatory imaging, preoperative computed tomography (CT) angiography imaging was reviewed when available, with specific attention to patency of the visceral, pelvic, and infrainguinal branch vessels. Operative notes were reviewed to identify the treatment modality and relevant intraoperative details, and inpatient and outpatient documentation was reviewed to identify perioperative deaths and major complications. The primary outcome was 30-day all-cause mortality. Secondary outcomes included 30-day cardiovascular, pulmonary, and other complication rates.
Data were compiled in Excel (Microsoft, Redmond, Wash) and analyzed using Stata SE 15.1 (StataCorp LLC, College Station, Tex). Comparisons of baseline characteristics and 30-day outcomes were performed by Student t-test (for continuous data with two groups), analysis of variance (for continuous data with more than two groups), or Fisher exact test (for categorical data) or their nonparametric equivalents as appropriate. The primary outcome was further studied by logistic regression modeling to identify risk factors associated with 30-day mortality. After identification of univariate factors, construction of a multivariate model was attempted by both forward and backward stepwise selection methods using a significance level of .20 for entry; however, as many patients were taken to the operating room with only a limited preoperative evaluation, missing data precluded the creation of a stable multivariate model.
RESULTS
We identified 66 patients who presented with AAO and underwent revascularization. Of these, 1 patient was excluded for a prior aortobifemoral bypass; the remaining 65 patients composed the cohort for our study. Baseline characteristics for these patients are shown in , which was abnormally elevated in 66.0% (mean value of 3.1 6 2.9 mmol/L; the normal value at our institution is #1.6 mmol/L). Preoperative CT angiography images were available for review in 44 patients (67.7%); these were supplemented with diagnostic angiograms and additional anatomic information found in select operative reports. Occlusion of the aorta extended above the level of the renal arteries in one patient, between the renal arteries and inferior mesenteric artery in 60.8%, and distal to the inferior mesenteric artery in 37.3%. The internal iliac arteries were occluded bilaterally in 34.7% and unilaterally in 10.2%. The external iliac arteries were occluded bilaterally in 16.7% and unilaterally in 6.3%. Based on presence of atherosclerotic disease in the aortoiliac segment, the suspected cause of occlusion was embolic in 15 patients (34.1%) and thrombotic in 29 patients (65.9%). The duration from presentation to the hospital to the start of treatment also varied widely, with a median of 9.1 hours (interquartile range, 3.3 hours-1.8 days); 43.8% of patients were treated within 6 hours of initial presentation. The treatment modality was axillobifemoral bypass in 36 (55.4%), aortoiliac stenting in 10 (15.4%, with 3 patients first undergoing catheter-directed thrombolysis and 5 patients first undergoing thromboembolectomy), aortoiliac thromboembolectomy without stenting in 10 (15.4%), and aortobifemoral bypass in 9 (13.9%). Mean operative times for these procedures were 234 6 73, 183 6 36, 180 6 82, and 375 6 199 minutes, respectively (P < .001). Baseline characteristics stratified by treatment group are shown in Table II . Aortobifemoral bypasses were performed in younger patients with lower rates of cardiac comorbidities. Patients undergoing isolated thromboembolectomy without stenting, associated with the shortest operative times, had the highest Rutherford acute limb ischemia classes and the highest lactate levels. Unilateral or bilateral major amputation was performed as part of the index operation in 10 patients (15.4%) and four-compartment leg fasciotomies in 26 patients (40.0%); no infrainguinal revascularizations were performed during the index operation. The 10 patients requiring immediate amputation were of similar age to the overall cohort (62.6 6 10.0 years) but were more likely to have presented with a motor deficit (90%), a locked ankle (70%), or an elevated lactate level (5.0 6 5.1 mmol/L).
Postoperative outcomes are summarized in Table III . The overall 30-day mortality was 27.7%; in-hospital mortality was 26.2%, and there were no intraoperative deaths. The highest 30-day mortality was observed in patients aged 60 years or older (40.5%), patients with an elevated lactate level on presentation (45.5%), and patients with either unilateral or bilateral lower extremity motor deficit on presentation (36.6%). Univariate risk factors of 30-day mortality included age $60 years, presentation with motor deficit or elevated lactate level, history of prior stroke, and bilateral internal iliac artery occlusion on CT angiography (Table IV) . Treatment modality was not a predictor of mortality (P ¼ .20). Other branch vessel occlusions on imaging, other baseline comorbidities, and the time to treatment were all explored and found not to be associated with mortality. As only 50 patients had a lactate level determined and 44 had CT angiography performed, at least one variable was missing in 30 patients (46.2%). The patients with complete data were not thought to be representative of the entire sample, and multivariate logistic regression modeling was not attempted.
The median length of hospital stay was 12 days (interquartile range, 8-23.5 days; range, 0-55 days). At least one complication occurred in 78.5% of all patients and 70.8% of patients who survived to discharge (Table III) . Acute kidney injury (56.9%), respiratory failure (46.2%), and cardiovascular complications (33.9%) were most common. Three patients (4.6%) returned to the operating room for continuation of ongoing thrombolysis and aortoiliac stenting; there were no unplanned aortarelated reoperations. Seven patients (10.8%) required a laparotomy for resection of ischemic bowel (six cases, with one requiring superior mesenteric artery embolectomy) or cholecystectomy. Nine patients (13.8%) required a lower extremity reoperation: four for revascularization for ongoing leg ischemia, two for fasciotomies, and three for major amputation. The resultant major amputation rate at 30 days was 15.4%, with 7.7% requiring bilateral major amputation.
DISCUSSION
AAO is a life-threatening emergency. As the current body of literature on these patients is sparse, our objective with this study was to describe the typical presentation, treatment modalities, and outcomes after revascularization in a contemporary cohort of patients with AAO. In this study, which is the largest singleinstitution series of AAO, we found that these patients have a striking 30-day mortality of 27.7%. Significant risk factors of 30-day mortality included older age and presentation with motor deficit, elevated lactate level ($1.7 mmol/L), and bilateral internal iliac artery occlusion. Even in survivors, major perioperative complications were common, and the median length of stay was nearly 2 weeks.
Outcomes after revascularization for AAO are poorly described and limited mostly to descriptive case series. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] The largest previous study, involving 48 patients, was performed by Babu et al 1 and included patients presenting as early as 1974; these investigators reported a 52% mortality. Several other smaller studies have been performed, most of them before 2000 (Table V) and predating the modern endovascular era, which offers additional treatment strategies in the aortoiliac segment. The literature shows a trend over time toward a modest improvement in postoperative mortality, and our reported mortality rate of 27.7% is consistent with smaller contemporary studies (Fig) . Given the fairly small magnitude of improvement over time, this may reflect advancements in critical care medicine as opposed to surgical intervention. To put this mortality rate into perspective, single-center studies have reported contemporary mortality rates after ruptured abdominal aortic aneurysm repair as low as 18% with the use of endovascular balloon control and enhanced perioperative care. 20 Our findings in this study elucidate the typical practice patterns at our institution in patients with AAO. The axillobifemoral bypass is an expedient and safe procedure that offers immediate reperfusion to the lower extremities while avoiding direct aortic revascularization. This is the treatment modality chosen in most of our patients and would be an acceptable treatment modality in nearly all patients with AAO. Although evaluation of its patency in the setting of AAO is limited, previous studies have shown reasonable durability in patients treated for chronic aortoiliac occlusive disease with primary patency rates as high as 74% at 5 years. 21, 22 In select situations, an alternative modality was believed to be favorable in some patients with AAO. In the absence of motor deficits, aortobifemoral bypasses are occasionally performed as a more durable solution in younger, healthier patients who will tolerate the physiologic stresses associated with laparotomy and aortic cross-clamping. At the other end of the spectrum, aortoiliac thromboembolectomy is best used in the highest risk patients and is associated with the shortest operative times. We attempt thromboembolectomy only in patients with a minimally diseased aortoiliac segment. Patients with chronic atherosclerotic disease in this area or those with prior iliac stents are inappropriate candidates for isolated thromboembolectomy and are better treated with a true reconstructive procedure. Aortoiliac stenting certainly provides another option for revascularization of these patients, but at our institution, this is generally reserved for patients with lower thrombus burden and especially those in whom the occlusion is sufficiently distal to the renal arteries to minimize the chance of embolization. When amputation is known to be necessary at the index operation, it is performed before revascularization to minimize the reperfusion insult; when a limb is questionably viable, revascularization is performed first. Additional adjuncts to mitigate the metabolic derangements associated with reperfusion include a slow or intermittent reperfusion of each extremity as well as intravenous administration of calcium and bicarbonate. Given the pathophysiologic mechanism of AAO, it is not surprising that the most significant risk factors of mortality are those associated with clinical, biochemical, or radiographic evidence of greater ischemic burden (motor deficit, elevated lactate, and bilateral internal iliac artery occlusion, respectively). We were not able to construct a multivariate model to assess independence of these risk factors because many patients are taken promptly to the operating room without a thorough preoperative evaluation, and thus laboratory values and imaging were not universally available in this population of patients. Whereas some history and physical examination findings, such as severe irreversible leg ischemia, can help to identify patients at the highest risk, other highrisk patients may not be immediately apparent without further evaluation. Our results suggest that from a risk stratification standpoint, patients and surgeons may benefit from a more complete evaluation before proceeding with revascularization. As an example, lactate level is a relatively quick and inexpensive diagnostic test that in our cohort could identify a group of patients with a mortality risk of nearly 50%. In addition, an axial imaging study such as CT angiography is critical to the evaluation of these patients and may reveal an unanticipated cause of the occlusion, such as an aortic dissection, which would alter both the management strategy and the prognosis of the patient. Although we were able to review CT scans in only 44 patients, we suspect the remainder had imaging studies performed at an outside institution that were not available for retrospective evaluation. A more thorough diagnostic evaluation may aid both providers and patients in having a more informed conversation about the true risk of mortality even with appropriate revascularization and may in fact lead to some patients declining to proceed with an operation. Whereas delays in presentation of the patient are unavoidable, delays in diagnosis and treatment are a potential area for improvement in the management of these patients. Although it was difficult to measure delay in diagnosis retrospectively, we were able to objectively measure the time between initial presentation and start of the operation. We found that only 43.8% of patients were treated within a 6-hour window of presentation to our institution, and we suspect that delay in diagnosis is a major reason for delays in treatment in many of these patients. Whereas some AAOs are recognized promptly, our experience shows that patients commonly undergo workup for more common causes of bilateral lower extremity motor or sensory dysfunction (most notably stroke or spinal cord diseases). This may cause significant delay before vascular surgery consultation, a concern also noted by Meagher et al. 19 As with any rare disease, diagnosis of AAO is challenging without a high index of suspicion. Education of emergency medicine, internal medicine, and other referring providers may help to address delays in diagnosis such that the vascular surgeon can offer expedient revascularization and minimize the physiologic insult to the patient. There are a number of limitations to this retrospective study. Our sample size was limited because of the uncommon nature of AAO, although to our knowledge, this study currently represents the largest series of such patients. When multiple revascularization procedures were performed during the index operation, we were able to identify the definitive procedure but unable to determine intention to treat retrospectively. In addition, there was probably selection bias in the treatment modality selected for each patient as well as selection bias in determining which patients should be offered revascularization. In patients who were not revascularized, the AAO was likely universally fatal, and including these patients would have increased the overall mortality in our cohort. Whereas our study was focused on risk factors for mortality, there are many other adverse outcomes (such as amputation) that significantly affect quality of life and should also play a role in decisionmaking. Lower event rates for these complications limit our ability to identify risk factors, which are likely similar to those for mortality. Finally, there was limited documentation available on specific timing of symptom onset and diagnosis of the aortic occlusion, limiting our ability to assess the presence or extent of delays in presentation or diagnosis. Despite these limitations, we think that this study may help inform selection of patients and risk stratification in patients presenting with AAO.
CONCLUSIONS AAO is a rare but devastating condition. Even with revascularization, patients are at high risk of mortality and numerous life-threatening complications. The patients at highest risk are older patients presenting with a unilateral or bilateral lower extremity motor deficit, elevated lactate level, or bilateral internal iliac artery occlusions preoperatively. These factors may be used for risk stratification to select appropriate patients for revascularization and to better counsel patients about expected postoperative outcomes.
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